1. Home
  2. AMPH vs ALEX Comparison

AMPH vs ALEX Comparison

Compare AMPH & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • ALEX
  • Stock Information
  • Founded
  • AMPH 1996
  • ALEX 1870
  • Country
  • AMPH United States
  • ALEX United States
  • Employees
  • AMPH N/A
  • ALEX N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • ALEX Real Estate Investment Trusts
  • Sector
  • AMPH Health Care
  • ALEX Real Estate
  • Exchange
  • AMPH Nasdaq
  • ALEX Nasdaq
  • Market Cap
  • AMPH 1.1B
  • ALEX 1.3B
  • IPO Year
  • AMPH 2014
  • ALEX N/A
  • Fundamental
  • Price
  • AMPH $21.70
  • ALEX $17.89
  • Analyst Decision
  • AMPH Hold
  • ALEX Buy
  • Analyst Count
  • AMPH 5
  • ALEX 3
  • Target Price
  • AMPH $38.00
  • ALEX $23.00
  • AVG Volume (30 Days)
  • AMPH 501.2K
  • ALEX 398.1K
  • Earning Date
  • AMPH 08-06-2025
  • ALEX 07-24-2025
  • Dividend Yield
  • AMPH N/A
  • ALEX 5.04%
  • EPS Growth
  • AMPH N/A
  • ALEX 38.72
  • EPS
  • AMPH 2.77
  • ALEX 0.85
  • Revenue
  • AMPH $730,659,000.00
  • ALEX $236,060,000.00
  • Revenue This Year
  • AMPH $0.67
  • ALEX N/A
  • Revenue Next Year
  • AMPH $5.18
  • ALEX $2.06
  • P/E Ratio
  • AMPH $7.83
  • ALEX $20.10
  • Revenue Growth
  • AMPH 8.05
  • ALEX 6.41
  • 52 Week Low
  • AMPH $21.48
  • ALEX $15.70
  • 52 Week High
  • AMPH $53.96
  • ALEX $20.30
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 28.01
  • ALEX 50.54
  • Support Level
  • AMPH $22.81
  • ALEX $17.66
  • Resistance Level
  • AMPH $23.77
  • ALEX $18.02
  • Average True Range (ATR)
  • AMPH 0.76
  • ALEX 0.30
  • MACD
  • AMPH -0.20
  • ALEX -0.03
  • Stochastic Oscillator
  • AMPH 9.27
  • ALEX 46.58

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

Share on Social Networks: